To help you in this analysis, in this article, MICA: Discusses risks posed by compounded drugs generally
Every legitimate compounded GLP-1 should disclose active peptide and concentration (mg/mL), solvent (usually bacteriostatic water), and any additives (B12, niacinamide, lidocaine)
GLP-1s are FDA-approved and doctor-supervised They target hunger at the root cause, not just the symptoms Theyre trusted by celebrities and recommended by physicians Bottom line
They also reported feeling less intoxicated early on
Subcutaneous use is uncommon and dose-limited
This is the formidable challenge that traditional treatments struggle to overcome, and it's precisely where the potential of a systemic agent like BPC 157 becomes so compelling